Tata India Pharma & Healthcare Fund Direct Growth

Tata India Pharma & Healthcare Fund Direct Growth

Equity

Tata Mutual Fund

Sector - Healthcare

Get the latest NAV of Tata India Pharma & Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹36.02

▼-0.3%1D

NAV as on 15 Sep 2025

14.1%/per year

Since Inception

Absolute Gain%

▲▼

3460 people have invested ₹ 1.5Cr in Tata India Pharma & Healthcare Fund Direct Growth in the last three months

Tata India Pharma & Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (15-Sep-25)

The fund has consistently outperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.

Period
1M
3M
6M
1Y
3Y
5Y
This Fund
-0.32%
3.74%
13.84%
-0.58%
25.59%
20.35%
Nifty 500
2.36%
1.35%
15.07%
-2.98%
14.22%
19.38%
Sector - Healthcare Avg
2.19%
2.94%
13.42%
0.24%
23.5%
19.33%
Best in Sector - Healthcare
3.71%
5.81%
17.3%
10.19%
29.51%
22.91%
Worst in Sector - Healthcare
0.8%
0.18%
9.96%
-10.29%
21.72%
16.4%
Category Rank
2/8
3/8
3/8
2/8
2/8
--

Tata India Pharma & Healthcare Fund Ranking and Peer Comparison

Ranked based on performance, risk management and cost efficiency

1
/8
94% Performance
47% Risk Management
83% Cost

Ranked 1 out of 8 mutual funds in the sector - healthcare category as per INDmoney.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
3Y Alpha
3Y Beta
3Y Sharpe
3Y Sortino
3Y Info Ratio
Tata India Pharma & Healthcare Fund
1/8
1,309Cr
0.62%
-0.58%
25.59%
4.38
0.94
1.08
1.95
1.35
SBI Healthcare Opportunities Fund Direct Growth
2/8
3,963Cr
0.91%
4.11%
27.28%
4.73
0.84
1.36
2.55
0.72
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
3/8
6,162Cr
1.04%
4.02%
29.72%
4.41
0.94
1.31
2.40
1.42
DSP Healthcare Fund Direct Growth
4/8
3,107Cr
0.56%
-1.44%
25.19%
3.64
0.84
1.22
2.38
0.23
See all
Positive: Generated Consistent Returns
Generated Consistent Returns
Positive: Consistently beats benchmark
Consistently beats benchmark
Positive: 5Y returns in the top 25% of the category
5Y returns in the top 25% of the category
Negative: Highly volatile within category
Highly volatile within category

Tata India Pharma & Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

Tata India Pharma & Healthcare Fund Asset Allocation

See fund asset allocation details as on (14-Sep-25)

Fund Distribution

as on (14-Sep-25)

Large cap
44.5%
Small cap
35.4%
Mid cap
17.5%
Small Cap allocation has gone up from 34.5% to 35.4%
Small Cap allocation has gone up from 34.5% to 35.4%
Mid Cap allocation has gone up from 15.5% to 17.5%
Mid Cap allocation has gone up from 15.5% to 17.5%
Large Cap allocation has gone up from 43.8% to 44.5%
Large Cap allocation has gone up from 43.8% to 44.5%
Cash allocation has gone down from 6.2% to 2.6%
Cash allocation has gone down from 6.2% to 2.6%

Tata India Pharma & Healthcare Fund Sector Allocation

See fund sector allocation details as on (14-Sep-25)

Sector Allocation

Health
97.8%
Basic Materials
2.2%

Top 3 Sectors in August were Health, Financial Services & Basic Materials

Aug'25

Health

97%

Financial Services

2%

Basic Materials

1%

Jul'25

Health

98%

Financial Services

2%

Tata India Pharma & Healthcare Fund Holdings Details

as on (31-Aug-25)

Top Stocks bought last month
Divi's Laboratories Ltd's allocation increased from 3.06% to 3.9%
Divi's Laboratories Ltd's allocation increased from 3.06% to 3.9%
HealthCare Global Enterprises Ltd's allocation increased from 4.38% to 4.85%
HealthCare Global Enterprises Ltd's allocation increased from 4.38% to 4.85%
Ajanta Pharma Ltd's allocation increased from 2.67% to 3.03%
Ajanta Pharma Ltd's allocation increased from 2.67% to 3.03%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 10.92 % to 9.94 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 10.92 % to 9.94 %
Apollo Hospitals Enterprise Ltd's allocation decreased from 5.2 % to 5.15 %
Apollo Hospitals Enterprise Ltd's allocation decreased from 5.2 % to 5.15 %
Fortis Healthcare Ltd's allocation decreased from 4 % to 3.69 %
Fortis Healthcare Ltd's allocation decreased from 4 % to 3.69 %

Tata India Pharma & Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio0.62%
Benchmark
Nifty Pharma TR INR
AUM₹1309 Cr
Inception Date28 December, 2015
Min Lumpsum/SIP₹5000/₹100
Exit Load
0.2%
Lock InNo Lock-in
TurnOver
11.18%
Risk
Risk meter
pointer
Very High Risk

About Tata India Pharma & Healthcare Fund

Tata India Pharma & Healthcare Fund Direct Growth is an equity fund. This fund was started on 28 December, 2015. The fund is managed by Rajat Srivastava. The fund could potentially beat inflation in the long-run.

Key Parameters

  1. Tata India Pharma & Healthcare Fund Direct Growth has ₹1309 Cr worth of assets under management (AUM) as on Sep 2025 and is more than category average.
  2. The fund has an expense ratio 0.6.

Returns

Tata India Pharma & Healthcare Fund Direct Growth has given a CAGR return of 14.10% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of -0.58%, 25.59% and 20.35% respectively.

Holdings

Tata India Pharma & Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Financial Services, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Apollo Hospitals Enterprise Ltd, HealthCare Global Enterprises Ltd, Lupin Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of Tata India Pharma & Healthcare Fund Direct Growth

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 100.00. Tata India Pharma & Healthcare Fund Direct Growth has no lock in period.

Fund Manager

Rajat Srivastava

Fund Manager of Tata India Pharma & Healthcare Fund Direct Growth, since 16 September 2024

Learn more about Tata Mutual Fund
Parameters
Aug'25
Jul'25
Jun'25
AUM
₹ 1.3K Cr
₹ 1.3K Cr
₹ 1.3K Cr
  • AUM of the fund stands at 1.3K Cr as of Aug'25
  • AUM decreased by 30.4 Cr between Aug'25 and Jul'25

Compare Tata India Pharma & Healthcare Fund

Tata India Pharma & Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for Tata India Pharma & Healthcare Fund Direct Growth

How do I invest in Tata India Pharma & Healthcare Fund?

INDmoney makes it simple to invest in the Tata India Pharma & Healthcare Fund. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘Tata India Pharma & Healthcare Fund’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of Tata India Pharma & Healthcare Fund?

The NAV of the fund today is ₹36.02. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

Tata India Pharma & Healthcare Fund fund has generated a return of -0.58% in 1 year, 25.59% in 3 years, 20.35% in 5 years.

Who is the fund manager of Tata India Pharma & Healthcare Fund?

The fund managers are Rajat Srivastava.

What is the exit load of the fund?

The exit load is 0.25% if redeemed in 0-30 Days. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 0.62%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹1309 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of Tata India Pharma & Healthcare Fund?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(9.94%), Cipla Ltd(6.92%), Apollo Hospitals Enterprise Ltd(5.15%)